Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Bone and Mineral
- Vol. 5 (2), 183-192
- https://doi.org/10.1016/0169-6009(89)90095-0
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- PREVENTION OF STEROID-INDUCED OSTEOPOROSIS WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (APD)The Lancet, 1988
- Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).BMJ, 1987
- REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENTThe Lancet, 1987
- Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chlorideThe American Journal of Medicine, 1987
- Efficacious Management with Aminobisphosphonate (APD) in Paget??s Disease of BonePublished by Wolters Kluwer Health ,1987
- Measurement of bone mineral content (BMC) of the lumbar spine, I. Theory and application of a new two-dimensional dual-photon attenuation methodScandinavian Journal of Clinical and Laboratory Investigation, 1980
- TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGENThe Lancet, 1976
- A specific method for the analysis of hydroxyproline in tissues and urineAnalytical Biochemistry, 1960